Increased Exacerbation Reduction Over Time with Tezepelumab in Severe Asthma: CROSSROADS-4. // The Journal of Allergy and Clinical Immunology: In Practice. – URL: https://www.sciencedirect.com/science/article/pii/S2213219826009025?dgcid=rss_sd_all
Increased Exacerbation Reduction Over Time with Tezepelumab in Severe Asthma: CROSSROADS-4. The Journal of Allergy and Clinical Immunology: In Practice. https://www.sciencedirect.com/science/article/pii/S2213219826009025?dgcid=rss_sd_all
“Increased Exacerbation Reduction Over Time with Tezepelumab in Severe Asthma: CROSSROADS-4.” The Journal of Allergy and Clinical Immunology: In Practice.
@article{article108801,
title = {Increased Exacerbation Reduction Over Time with Tezepelumab in Severe Asthma: CROSSROADS-4},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
url = {https://www.sciencedirect.com/science/article/pii/S2213219826009025?dgcid=rss_sd_all}
}